首页> 外文期刊>British Journal of Cancer >Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
【24h】

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity

机译:血清CXCL16升高是卵巢癌存活率低的独立预测因子,可能反映了转移前ADAM蛋白酶的活性

获取原文
       

摘要

Background:In certain cancers, expression of CXCL16 and its receptor CXCR6 associate with lymphocyte infiltration, possibly aiding anti-tumour immune response. In other cancers, CXCL16 and CXCR6 associate with pro-metastatic activity. In the current study, we aimed to characterise the role of CXCL16, sCXCL16, and CXCR6 in ovarian cancer (OC).
机译:背景:在某些癌症中,CXCL16及其受体CXCR6的表达与淋巴细胞浸润相关,可能有助于抗肿瘤免疫反应。在其他癌症中,CXCL16和CXCR6与转移活性有关。在当前的研究中,我们旨在表征CXCL16,sCXCL16和CXCR6在卵巢癌(OC)中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号